These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 10867550)

  • 1. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.
    Ricaurte GA; Yuan J; McCann UD
    Neuropsychobiology; 2000; 42(1):5-10. PubMed ID: 10867550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
    McCann UD; Eligulashvili V; Ricaurte GA
    Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    Ricaurte GA; McCann UD; Szabo Z; Scheffel U
    Toxicol Lett; 2000 Mar; 112-113():143-6. PubMed ID: 10720723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research.
    Curran HV
    Neuropsychobiology; 2000; 42(1):34-41. PubMed ID: 10867554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
    Baumann MH; Wang X; Rothman RB
    Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
    Wallinga AE; ten Voorde AM; de Boer SF; Koolhaas JM; Buwalda B
    Eur J Pharmacol; 2009 Sep; 618(1-3):22-7. PubMed ID: 19616536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
    Izco M; Orio L; O'Shea E; Colado MI
    Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging in human MDMA (Ecstasy) users.
    Cowan RL; Roberts DM; Joers JM
    Ann N Y Acad Sci; 2008 Oct; 1139():291-8. PubMed ID: 18991874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.
    Barbosa DJ; Capela JP; Silva R; Ferreira LM; Branco PS; Fernandes E; Bastos ML; Carvalho F
    Arch Toxicol; 2014 Feb; 88(2):515-31. PubMed ID: 24177245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI.
    Schouw ML; Gevers S; Caan MW; Majoie CB; Booij J; Nederveen AJ; Reneman L
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):537-45. PubMed ID: 22209360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).
    Baumann MH; Rothman RB
    Int Rev Neurobiol; 2009; 88():257-96. PubMed ID: 19897081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.
    Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
    Orio L; Llopis N; Torres E; Izco M; O'Shea E; Colado MI
    Neurotox Res; 2010 Aug; 18(2):187-99. PubMed ID: 19777321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
    Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA
    Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.
    McCann UD; Szabo Z; Scheffel U; Dannals RF; Ricaurte GA
    Lancet; 1998 Oct; 352(9138):1433-7. PubMed ID: 9807990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.